A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Trilostane | CAS 13647-35-3 - Request Quote

Picture of Trilostane
SZ CAT No:SZ-T108001
CAS No
13647-35-3
Mol.F.
C20H27NO3
Mol.Wt.
329.4
Inv. Status
In Stock
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Trilostane is chemically (1aR,4aR,4bS,6aS,7S,9aS,9bS,11aS)-2,7-dihydroxy-4a,6a-dimethyl-1a,4,4a,4b,5,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[1,10a-b]oxirene-3-carbonitrile. Trilostane is supplied with detailed characterization data compliant with regulatory guideline. Trilostane can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Trilostane.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 13647-35-3

Purchase 13647-35-3

Order 13647-35-3

Enquire 13647-35-3

price of 13647-35-3

13647-35-3 Supplier

13647-35-3 Manufacturer

13647-35-3 Exporter

buy high quality Trilostane

Purchase Trilostane

Trilostane suppliers

Trilostane manufacturers

Trilostane price

Order Trilostane

Enquire Trilostane

Trilostane cost

Trilostane Supplier

Trilostane Distributor

Trilostane for Method Validation

Trilostane Reference Standard

Trilostane for ANDA Filing

Trilostane for Forced Degradation Studies

Trilostane Identification Standards

Trilostane for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,